Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sarah K. Jimenez"'
Publikováno v:
The Journal of Physiological Sciences. 61:331-336
We have investigated whether acute (swimming) exercise is sufficient to have sustained beneficial effects against cardiac functional decline observed after high-dose isoproterenol administration. Mice were subjected to one bout of swimming for 30 min
Autor:
Zhi-Sheng Jiang, Xin Ma, Sarah K. Jimenez, Elissavet Kardami, Karen A. Detillieux, Jon-Jon Santiago, Peter A. Cattini
Publikováno v:
Heart Failure Reviews. 12:267-277
Boosting myocardial resistance to acute as well as chronic ischemic damage would ameliorate the detrimental effects of numerous cardiac pathologies and reduce the probability of transition to heart failure. Experimental cardiology has pointed to isch
Autor:
Peter Zahradka, Peter A. Cattini, Sarah K. Jimenez, Farah Sheikh, Zhi-Sheng Jiang, Elissavet Kardami, Cheryl Hirst
Publikováno v:
Cardiovascular Research. 63:458-466
Fibroblast growth factor 2 (FGF-2), a multifunctional polypeptide that affects cell growth and differentiation and becomes upregulated by stress, is expressed as AUG-initiated 18 kDa FGF-2 or CUG-initiated 21-34 kDa (hi-FGF-2) isoforms. Animal models
Autor:
Elissavet Kardami, Farah Sheikh, Karen A. Detillieux, Yan Jin, Peter A. Cattini, Sarah K. Jimenez, Jamit Dhaliwal
Publikováno v:
Cardiovascular Research. 62:548-557
Objective: Fibroblast growth factor-2 (FGF-2) exerts its cardioprotective effect through cell surface receptor signaling and may play a role in the normal maintenance of a healthy myocardium. One mechanism of FGF-2 release from contracting cardiomyoc
Autor:
Peter Nickerson, Sarah K. Jimenez, Farah Sheikh, Johanna T. A. Meij, Peter A. Cattini, Elissavet Kardami
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 282:H547-H555
Fibroblast growth factor-2 (FGF-2) is cardioprotective when added exogenously, stimulates cardiac myocyte proliferation, and is a mediator of tissue repair after injury. Furthermore, transgenic (TG) mice overexpressing FGF-2 in cardiac muscle demonst
Abstract 340: Heat Shock Proteins HSP90 and HSP70 Mediate Opioid- and GSK3β-induced Cardioprotection
Publikováno v:
Circulation Research. 115
Previously, opioids were established to reduce myocardial injury in an ischemic preconditioning (IPC)-like manner, involving a central and downstream role of glycogen synthase kinase-3 beta (GSK-3β) inhibition. However, the mechanism of GSK-3β inhi
Publikováno v:
Molecular and cellular biochemistry. 357(1-2)
Fibroblast growth factor-2 (FGF-2) is implicated in cardioprotection. However, previously we found that chronic elevation in cardiac FGF-2 levels in transgenic mice was associated with exaggerated, cyclosporine A-preventable, cellular infiltration af
Publikováno v:
Myocardial Ischemia ISBN: 9780387286570
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::205a0d73d86a89e0a09bbbb5e6e734db
https://doi.org/10.1007/0-387-28658-6_7
https://doi.org/10.1007/0-387-28658-6_7
Autor:
Sarah K. Jimenez, Peter A. Cattini, Karen A. Detillieux, David P. Sontag, Elissavet Kardami, Peter Nickerson
Publikováno v:
Signal Transduction and Cardiac Hypertrophy ISBN: 9781461350323
Fibroblast growth factor (FGF)-2 is a polypeptide growth factor which plays multiple roles in the mammalian cardiovascular system, having direct proliferative, migratory and differentiation effects on cardiac myocytes, fibroblasts, smooth muscle and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a3c5264092b2d54115903e37d3e8a84
https://doi.org/10.1007/978-1-4615-0347-7_27
https://doi.org/10.1007/978-1-4615-0347-7_27
Publikováno v:
Journal of Molecular and Cellular Cardiology. 44:790